-+ 0.00%
-+ 0.00%
-+ 0.00%

Intensity Therapeutics Q2 EPS $(1.11), Inline

Benzinga·08/11/2026 11:52:16
Listen to the news
Intensity Therapeutics (NASDAQ:INTS) reported quarterly losses of $(1.11) per share which met the analyst consensus estimate. This is a 66.96 percent increase over losses of $(3.36) per share from the same period last year.